Metsä Board Oyj (METSA.HE)

Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.

Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.

Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.

Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.

Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.

Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.

Reduced diluted shares while STERV.HE is at 0.11%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.

OCF growth above 1.5x STERV.HE's 304.48%. David Dodd would confirm a clear edge in underlying cash generation.

FCF growth above 1.5x STERV.HE's 267.69%. David Dodd would verify if the firm’s strategic investments yield superior returns.

10Y OCF/share CAGR above 1.5x STERV.HE's 83.62%. David Dodd would check if a superior product mix or cost edge drives this outperformance.

5Y OCF/share CAGR above 1.5x STERV.HE's 10.75%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.

3Y OCF/share CAGR above 1.5x STERV.HE's 80.94%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.

Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.

5Y net income/share CAGR 1.25-1.5x STERV.HE's 100.27%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.

Positive short-term CAGR while STERV.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.

No Data available this quarter, please select a different quarter.

Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.

Our AR growth while STERV.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.

We show growth while STERV.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.

Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.

Positive BV/share change while STERV.HE is negative. John Neff sees a clear edge over a competitor losing equity.

Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.

No Data available this quarter, please select a different quarter.

We expand SG&A while STERV.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.